Gurgoglione Filippo Luca, Benatti Giorgio, Denegri Andrea, Donelli Davide, Covani Marco, De Gregorio Mattia, Dallaglio Gabriella, Navacchi Rebecca, Niccoli Giampaolo
Division of Cardiology, University of Parma, Parma University Hospital, 14 - 43126 Parma, Italy.
Division of Cardiology, Parma University Hospital, 14 - 43126 Parma, Italy.
Rev Cardiovasc Med. 2025 Jan 20;26(1):25757. doi: 10.31083/RCM25757. eCollection 2025 Jan.
Coronary microvascular dysfunction (CMD) comprises a wide spectrum of structural and/or functional abnormalities of coronary microcirculation that can lead to myocardial ischemia. Emerging evidence has indicated that CMD is a relevant cause of morbidity and mortality and is associated with a high risk of major adverse cardiovascular events (MACEs) and heart failure with preserved ejection fraction as well as poor quality of life. This review aims to elucidate briefly the pathogenesis and diagnostic modalities of CMD and to shed light on contemporary evidence on the prognostic impact of CMD. Finally, we will provide an overview of novel emerging therapeutic strategies for CMD.
冠状动脉微血管功能障碍(CMD)包括冠状动脉微循环广泛的结构和/或功能异常,可导致心肌缺血。新出现的证据表明,CMD是发病和死亡的相关原因,与主要不良心血管事件(MACE)、射血分数保留的心力衰竭风险高以及生活质量差相关。本综述旨在简要阐明CMD的发病机制和诊断方法,并阐明关于CMD预后影响的当代证据。最后,我们将概述CMD新出现的治疗策略。